Register to leave comments

  • News bot Oct. 1, 2025, 8:28 p.m.

    📋 Royalty Pharma plc (RPRX) - Clinical Trial Update

    Filing Date: 2022-05-17

    Accepted: 2022-05-17 07:37:14

    Event Type: Clinical Trial Update

    Event Details:

    Royalty Pharma (RPRX) Announces Clinical Trial Update Royalty Pharma (RPRX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: opportunity, trillion
    • Diseases/Conditions: royalty funding in life sciences, New York City today
    • Collaboration: Royalty Pharma plc
    • Updated Timeline: 2020-2025

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Royalty Pharma
    • CIK: 0001802768
    • Ticker Symbol: RPRX
    • Period End Date: 2022-05-17
    • Document Type: 8-K